ENLEOFEN BIO PTE. LTD.
Country of registration | Singapore |
Registration number | 201709350D |
Local SIC | |
Incorporation date | 4 Apr 2017 |
Company age | 9 years 2 months |
Official entity type | Private Limited Company |
No. of officers | 33 |
Contact
11 COLLYER QUAY, #17-00, THE ARCADE, Singapore 049317
This is the legal entity page of ENLEOFEN BIO PTE. LTD.. To access company info, company size, news , key makers’ emails, visit the profile pages above.
- ENLEOFEN BIOView MoreSingaporeEnleofen Bio is a biotech company focused on developing first-in-class antibody therapeutics for treating fibrotic human diseases. Founded as a spin-off from National Heart Centre Singapore, SingHealth, and Duke-NUS Medical School, we have secured Series A funding to translate research findings into life-saving treatments. Our lead antibodies are in clinical trials with the goal of creating a drug for treating multiple diseases without current treatment options.
Auditor | KPMG LLP |
Revenue | < 1m |
Share Capital - Ordinary shares | USD 123,284 |
Share Capital - Ordinary shares | SGD 20 |
Frequently Asked Questions (FAQ)
- What is the address of ENLEOFEN BIO PTE. LTD.?
- Where is ENLEOFEN BIO PTE. LTD.'s headquarter?
- What is ENLEOFEN BIO PTE. LTD.'s contact number?
- What ENLEOFEN BIO PTE. LTD.'s spending power?
- Does ENLEOFEN BIO PTE. LTD. have a presence in the domain it operates in?

